|
necroptotic process
|
GO_0070266 |
[A programmed necrotic cell death process which begins when a cell receives a signal (e.g. a ligand binding to a death receptor or to a Toll-like receptor), and proceeds through a series of biochemical events (signaling pathways), characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3) and by critical dependence on mixed lineage kinase domain-like (MLKL), and which typically lead to common morphological features of necrotic cell death. The process ends when the cell has died. The process is divided into a signaling phase, and an execution phase, which is triggered by the former.] |
|
obsolete oncosis
|
GO_0070267 |
[OBSOLETE. A cellular process that results in swelling of the cell body, and that is morphologically characteristic of necrotic cell death.] |
|
cornification
|
GO_0070268 |
[A type of programmed cell death that occurs in the epidermis, morphologically and biochemically distinct from apoptosis. It leads to the formation of corneocytes, i.e. dead keratinocytes containing an amalgam of specific proteins (e.g., keratin, loricrin, SPR and involucrin) and lipids (e.g., fatty acids and ceramides), which are necessary for the function of the cornified skin layer (mechanical resistance, elasticity, water repellence and structural stability).] |
|
pyroptotic inflammatory response
|
GO_0070269 |
[A gasdermin-dependent inflammatory response that is associated with the generation of pyrogenic mediators such as IL-1beta and IL-18. Gasdermins are activated by caspase-1 or caspase-4/11, or by certain granzymes. In some, but not all cells, it can lead to pyroptotic programmed cell death.] |
|
inflammatory response
|
GO_0006954 |
[The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.] |
|
obsolete heteroreceptor complex disassembly
|
GO_1905501 |
[OBSOLETE. The disaggregation of a heteroreceptor complex into its constituent components.] |
|
acetyl-CoA binding
|
GO_1905502 |
[Binding to acetyl-CoA, an acyl-CoA having acetyl as its S-acetyl component.] |
|
obsolete heteroreceptor complex assembly
|
GO_1905500 |
[OBSOLETE. The aggregation, arrangement and bonding together of a set of components to form a heteroreceptor complex.] |
|
positive regulation of motile cilium assembly
|
GO_1905505 |
[Any process that activates or increases the frequency, rate or extent of motile cilium assembly.] |
|
regulation of motile cilium assembly
|
GO_1905503 |
[Any process that modulates the frequency, rate or extent of motile cilium assembly.] |
|
gerontoplast stroma
|
GO_1905506 |
[Any plastid stroma that is part of a gerontoplast.] |
|
negative regulation of motile cilium assembly
|
GO_1905504 |
[Any process that stops, prevents or reduces the frequency, rate or extent of motile cilium assembly.] |
|
protein localization to interphase microtubule organizing center
|
GO_1905509 |
[A process in which a protein is transported to, or maintained in, a location within an interphase microtubule organizing center.] |
|
protein localization to microtubule organizing center
|
GO_1905508 |
[A process in which a protein is transported to, or maintained in, a location within a microtubule organizing center.] |
|
obsolete cytoplasmic sequestering of protein involved in mitotic G2 DNA damage checkpoint
|
GO_1905507 |
[OBSOLETE. Any cytoplasmic sequestering of protein that is involved in mitotic G2 DNA damage checkpoint.] |
|
regulation of short-term synaptic potentiation
|
GO_1905512 |
[Any process that modulates the frequency, rate or extent of short-term synaptic potentiation.] |
|
negative regulation of short-term synaptic potentiation
|
GO_1905513 |
[Any process that stops, prevents or reduces the frequency, rate or extent of short-term synaptic potentiation.] |
|
negative regulation of myosin II filament assembly
|
GO_1905510 |
[Any process that stops, prevents or reduces the frequency, rate or extent of myosin II filament assembly.] |
|
negative regulation of myosin II filament organization
|
GO_1904900 |
[Any process that stops, prevents or reduces the frequency, rate or extent of myosin II filament organization.] |
|
regulation of myosin II filament assembly
|
GO_0043520 |
[Any process that modulates the frequency, rate or extent of the formation of a bipolar filament composed of myosin II molecules.] |